Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Efficacy of Naltrexone Treatment as Augmentation to SSRI in OCD Patients

NCT00234689 is registered in ClinicalTrials.gov with Sheba Medical Center as lead sponsor.

NCT NCT00234689
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00234689 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Efficacy of Naltrexone Treatment as Augmentation to SSRI in OCD Patients
Lead sponsor
Sheba Medical Center
Phase
Not applicable
Overall status
Completed
Start date
January 31, 2002
Completion date
December 31, 2004
Enrollment
Not reported
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

obsessive compulsive disorder